(a)        Other items in the above table includes $7.6 million of restructuring costs during the three months ended December 30, 2021 and restructuring costs of $3.3 million and $27.9 million during the twelve months ended December 30, 2022 and 2021, respectively. The twelve months ended December 30, 2021 also includes $2.0 million of additional non-recurring personnel-related costs expenses related to new employee agreements.

The table below presents a reconciliation of free cash flow to net cash provided by operating activities, the most directly comparable GAAP financial measure (in thousands):

		For the Three Months Ended December 31,								For the Twelve Months Ended December 31,
			2022				2021				2022				2021
Net cash provided by operating activities		$	356,508			$	71,229			$	286,039			$	130,392
Purchases of property and equipment			(2,284	)			(634	)			(3,156	)			(2,511	)
Capitalized patent costs			(9,330	)			(5,271	)			(39,597	)			(33,416	)
Free cash flow3		$	344,894			$	65,324			$	243,286			$	94,465

« Previous Page 1 | 2 | 3 | 4 | 5 | 6 | 7  Next Page »